Earnings Outlook For ImmunoPrecise Antibodies
Portfolio Pulse from Benzinga Insights
ImmunoPrecise Antibodies (NASDAQ:IPA) is set to release its latest quarterly earnings report on September 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. Over the last 52-week period, shares are down 59.26%.
September 13, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ImmunoPrecise Antibodies is expected to report an EPS of $-0.15 in its upcoming earnings report. The company's stock has been on a downward trend, with shares down 59.26% over the last 52 weeks.
The company has a history of missing EPS estimates, which has been followed by drops in share price. Given the negative trend in the company's stock performance, it is likely that the upcoming earnings report could further impact the stock negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100